An interdisciplinary and comprehensive electronic cardiac rehabilitation programme to improve medication adherence in patients after percutaenous coronary intervention

An interdisciplinary and comprehensive e-cardiac rehabilitation to improve medication adherence in patients after PCIHjerterehabilitering (HR) bedrer medikamentetterlevelse etter utblokking av hjertets kransårer (PCI). eHjerteRehab er et personsentrert og digitalt HR program rettet mot å veilede pasienters egenmestring og forebygging av koronarsykdom. Formålet med studien er å evaluere effekten av eHjerteRehab på medikamentetterlevelse hos pasienter etter PCI.Postdoktorprosjektet er en del av eHjerteRehab, et personsentrert og digitalt hjerterehabiliteringsprogram rettet mot å veilede pasienters egenmestring og forebygging av koronarsykdom etter utblokking av hjertets kransårer. Formålet med prosjektet er å utvikle en medikamentmodul som skal innlemmes i eHjerteRehab, samt evaluere effekten av denne på medikamentetterlevelse. Aktiviteter gjennomført i 2023 1. Fem måneders postdoktor opphold ved Charles Perkins Centre, University of Sydney, Australia. Oppholdet førte blant annet til medforfatterskap på en systematisk oversiktsartikkel (Uptake and implementation of cardiac telerehabilitation: A systematic review of provider and system barriers and enablers) som er akseptert for publisering i International Journal of Medical Informatics. Resultater fra artikkelen er viktige i det videre arbeidet i postdoktorprosjektet. 2. Presentasjoner: 1) Pettersen, TR et al. Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. Winner of the Nursing and Allied Professions Investigator Award at the ESC Congress, Amsterdam, The Netherlands. Eur Heart J Vol 44, Issue Supplement_2, November 2023, ehad655.2879, 2) Pettersen TR. Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. Christmas seminar at the Centre for research on cardiac disease in women. Bergen, Norway 3) Pettersen TR. Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions. 28th Nordic-Baltic Congress of Cardiology, Reykjavik, Iceland. 3. Medforfatter på presentasjoner: 1) Hjertvikrem N, Pettersen TR, et al. Using registry data to determine actual cardiac rehabilitation participation after percutaneous coronary intervention. Moderated eposter at the ESC Congress, Amsterdam, The Netherlands. Eur Heart J Vol 44, Issue Supplement_2, November 2023, ehad655.2902 2) Ferrel-Yui D, …, Pettersen TR, et al. Uptake and implementation of telehealth-delivered cardiac rehabilitation: A systematic review of system and provider factors. Abstract presentation at the 71st Annual Scientific Meeting of the cardiac society of Australia and New Zealand, Adelaide, Australia 3) Ferrel-Yui D, …, Pettersen TR, et al. Uptake and implementation of telehealth-delivered cardiac rehabilitation: A systematic review of system and provider factors. Abstract presentation at the 32nd Annual Scientific Meeting (ASM) of the Australian Cardiovascular Health and Rehabilitation Association (ACRA), Perth, Australia 4) Hjertvikrem N, …, Pettersen TR, et al. Attribute development for a discrete choice experiment to elicit patient preferences for a digital cardiac rehabilitation programme: a qualitative study. Abstract presentation at the 28th Nordic-Baltic Congress of Cardiology, Reykjavik, Iceland (Awarded best abstract presentation) 5) Ramstad KJ, …, Pettersen TR, et al. Co-creation in the development of a digital cardiac rehabilitation programme. Abstract presentation at the 28th Nordic-Baltic Congress of Cardiology, Reykjavik, Iceland. 4. Medforfatter på publikasjoner: 1) Holm MS, …, Pettersen TR, et al. Patients’ experiences of in-hospital telemetry monitoring – a qualitative analysis. Eur J Cardiovasc Nurs 2023 Aug 17:zvad082, 2) Schjøtt J, Pettersen TR, et al. Nurses as adverse drug reaction reporting advocates. Eur J Cardiovasc Nurs Dec 14;22(8)765-768.